1. Home
  2. AGIO vs ALG Comparison

AGIO vs ALG Comparison

Compare AGIO & ALG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • ALG
  • Stock Information
  • Founded
  • AGIO 2007
  • ALG 1955
  • Country
  • AGIO United States
  • ALG United States
  • Employees
  • AGIO N/A
  • ALG N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • ALG Industrial Machinery/Components
  • Sector
  • AGIO Health Care
  • ALG Industrials
  • Exchange
  • AGIO Nasdaq
  • ALG Nasdaq
  • Market Cap
  • AGIO 2.3B
  • ALG 2.6B
  • IPO Year
  • AGIO 2013
  • ALG 1993
  • Fundamental
  • Price
  • AGIO $36.78
  • ALG $205.99
  • Analyst Decision
  • AGIO Buy
  • ALG Buy
  • Analyst Count
  • AGIO 6
  • ALG 2
  • Target Price
  • AGIO $57.00
  • ALG $242.50
  • AVG Volume (30 Days)
  • AGIO 779.8K
  • ALG 70.9K
  • Earning Date
  • AGIO 10-30-2025
  • ALG 10-30-2025
  • Dividend Yield
  • AGIO N/A
  • ALG 0.58%
  • EPS Growth
  • AGIO N/A
  • ALG N/A
  • EPS
  • AGIO 11.13
  • ALG 9.82
  • Revenue
  • AGIO $40,875,000.00
  • ALG $1,596,647,000.00
  • Revenue This Year
  • AGIO $28.19
  • ALG $1.20
  • Revenue Next Year
  • AGIO $152.14
  • ALG $5.89
  • P/E Ratio
  • AGIO $3.31
  • ALG $20.94
  • Revenue Growth
  • AGIO 30.57
  • ALG N/A
  • 52 Week Low
  • AGIO $23.42
  • ALG $157.07
  • 52 Week High
  • AGIO $62.58
  • ALG $233.29
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 48.43
  • ALG 40.15
  • Support Level
  • AGIO $34.97
  • ALG $207.79
  • Resistance Level
  • AGIO $37.91
  • ALG $212.13
  • Average True Range (ATR)
  • AGIO 1.67
  • ALG 4.45
  • MACD
  • AGIO -0.21
  • ALG -0.67
  • Stochastic Oscillator
  • AGIO 48.57
  • ALG 11.88

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

Share on Social Networks: